The objective of the study was to evaluate the efficacy of 17 alpha-hydroxyprogesterone caproate ( 17OHP-C ) in prolonging gestation in patients with a short cervix and other risk factors for preterm delivery , such as previous preterm birth , cervical surgery , uterine anomalies , or prenatal diethylstilbestrol ( DES ) exposure .